Samuel Zhang
Corporate Officer/Principal bei INNOVENT BIOLOGICS, INC.
Profil
Samuel Zhang is currently the Global Chief Business Officer at Innovent Biologics, Inc. He previously held positions as the Executive Director at Novartis Corp.
from 2013 to 2017, the Chief Business Officer at NeoImmuneTech, Inc. from 2019 to 2022, and the Vice President-Strategy & Business Development at Merus, Inc. from 2017 to 2019.
He also served as the Chief Business Officer at Gracell Biotechnologies, Inc. Dr. Zhang holds a doctorate degree from The Trustees of Columbia University in The City of New York, an undergraduate degree from Peking University, and an MBA from The Wharton School of the University of Pennsylvania.
Aktive Positionen von Samuel Zhang
| Unternehmen | Position | Beginn |
|---|---|---|
| INNOVENT BIOLOGICS, INC. | Corporate Officer/Principal | 30.04.2024 |
Ehemalige bekannte Positionen von Samuel Zhang
| Unternehmen | Position | Ende |
|---|---|---|
| NEOIMMUNETECH, INC. | Corporate Officer/Principal | 01.01.2022 |
Merus, Inc.
 Merus, Inc. Packaged SoftwareTechnology Services Part of Alpine SG LLC, Merus, Inc. develops and operates a cloud-based legal practice management platform. The private company is based in Oakland, CA. The company was founded in 2008 by Johnny Fuery. Merus was acquired by Alpine SG LLC on March 14, 2019. | Corporate Officer/Principal | 01.05.2019 |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Director/Board Member | 01.07.2017 |
| GRACELL BIOTECHNOLOGIES INC. | Corporate Officer/Principal | - |
Ausbildung von Samuel Zhang
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| Peking University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| INNOVENT BIOLOGICS, INC. | Health Technology |
| NEOIMMUNETECH, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
Merus, Inc.
Merus, Inc. Packaged SoftwareTechnology Services Part of Alpine SG LLC, Merus, Inc. develops and operates a cloud-based legal practice management platform. The private company is based in Oakland, CA. The company was founded in 2008 by Johnny Fuery. Merus was acquired by Alpine SG LLC on March 14, 2019. | Technology Services |
Gracell Biotechnologies, Inc.
 Gracell Biotechnologies, Inc. BiotechnologyHealth Technology Gracell Biotechnologies, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of discovering and developing cell therapies to resolve industry challenges and fulfill unmet medical needs in the treatment of cancer. The company was founded by Wei Cao in May 2017 and is headquartered in Suzhou, China. | Health Technology |
